April
McKinsey uses Chumbawamba to boost morale
The firm sought to rally partners at a meeting, but has been hit by news of a criminal investigation and lawsuit from a former senior partner in the past week.
- Ambereen Choudhury and Amy Bainbridge
June 2023
Do drug companies have too much influence on medical students?
Universities have done little to protect medical students from the undue influence of pharmaceutical companies.
- Julie Hare
September 2021
Sackler family keeps riches despite $6b deal to settle opioid claims
The bankruptcy settlement will end thousands of lawsuits over the deaths of more than 500,000 people across the US.
- Jan Hoffman
June 2021
Johnson & Johnson pays over $300m to settle opioid case
The agreement came just days before opening arguments in a sweeping trial targeting big pharmaceutical companies.
- Sarah Maslin Nir
February 2021
Mesoblast ‘excited’ by back pain trial results
Despite the mixed results, the regenerative medicine company plans to engage with the powerful US regulator after delivering the late results of its highly anticipated back pain trial.
- Carrie LaFrenz
McKinsey settles for $US573m over role in opioid crisis
Result comes after lawsuits unearthed a trove of documents showing how McKinsey drove sales of Purdue Pharma’s OxyContin painkiller amid an opioid epidemic in the US.
- Michael Forsythe and Walt Bogdanich
